Position in NVS
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$232,943
+$22,692 QoQ
Shares Held
1,525
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Jackson Hole Capital Partners, LLC holds $25,097,540 across 8 Drug Manufacturers - General names. NVS ranks #8 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
35,906 | $7,809,195 | |
| 2 | MRK |
Merck & Co., Inc.
|
62,790 | $7,553,009 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
33,305 | $4,641,717 | |
| 4 | PFE |
Pfizer Inc
|
120,319 | $3,378,557 | |
| 5 | LLY |
ELI LILLY & Co
|
911 | $837,910 | |
| 6 | JNJ |
Johnson & Johnson
|
1,589 | $388,415 | |
| 7 | AMGN |
Amgen Inc
|
727 | $255,794 | |
| 8 | NVS |
Novartis AG
This page
|
1,525 | $232,943 |
All Filings in NVS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $232,943 | 1,525 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $210,251 | 1,525 | Shares | Sole | 2026-01-30 | |
| No filing history on record for this holder in this stock. | ||||||